加载中
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
常规交易时段
US$0.358
−US$0.012 · -3.24%
盘中时间采用ET。市场数据可能有所延迟。
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
日内区间
当前US$0.358
52周区间
当前US$0.358
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
44
合理估值
情绪
50
多空交织
风险
67
高风险
动量
20
强势下行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
日内区间
当前US$0.358
52周区间
当前US$0.358
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 485.63万 USD | 337.1万 USD | 240.36万 USD | 359.48万 USD | — |
| 销货成本 | 329.8万 USD | 206.98万 USD | 180.46万 USD | 161.77万 USD | — |
| 毛利 | 155.83万 USD | 130.13万 USD | 59.89万 USD | 197.71万 USD | — |
| 销售、一般及管理费用 | 370.33万 USD | 267.43万 USD | 209.05万 USD | 2609.02万 USD | 13.56万 USD |
| 营业费用 | 493.93万 USD | 380.28万 USD | 300.81万 USD | 251.26万 USD | 13.56万 USD |
| 利息收入 | 3856 USD | 123 USD | — | — | 99 USD |
| 利息支出 | 5.05万 USD | 4.83万 USD | 4.28万 USD | 4.66万 USD | — |
| 折旧和摊销 | 112.95万 USD | 112.85万 USD | 90.34万 USD | 89.86万 USD | — |
| 营业利润 | −338.1万 USD | −250.15万 USD | −240.91万 USD | −53.55万 USD | −13.56万 USD |
| 净利润 | −200.84万 USD | −251.36万 USD | −230.4万 USD | −72.92万 USD | −11.96万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
